FDA panel overwhelmingly votes against Pfizer’s vaccine booster shots for the general population
In a big blow to Pfizer and other health officials pushing for a new round of jabs, scientists finally say enough is enough. This evening, The FDA advisory panel votes against Pfizer booster shots for the general population.
The FDA panel overwhelmingly rejects recommending Pfizer’s COVID-19 vaccine booster. In a vote of 16 to 3, the panel recommended against approving additional booster shots for the general population.
In July, Pfizer announced that it was developing a booster shot for the new covid variant. The pharmaceutical giant added that a third COVID-19 booster dose given about six months after the second shot improves the efficacy of the vaccine against new coronavirus variants. Pfizer said the effectiveness of the third COVID-19 booster dose is backed by initial data from their study on booster shots.
However, immediately after the company announced its plans for a third booster dose, the FDA and the Centers for Disease Control and Prevention (CDC) announced that fully vaccinated people do not need those types of booster shots.
Dr. Eli David, AI Researcher, and founder of DeepInstinctSec shared a screenshot of a slide from the FDA panel meeting.
This is breaking news. Please check back for updates later.